当前位置: 首页 >> 检索结果
1884. Recommendations for the reporting of specimens containing oral cavity and oropharynx neoplasms. Association of Directors of Anatomic and Surgical Pathology.1886. Northern Cancer Network guidelines for management of thyroid cancer.1887. NCCN Practice Guidelines for Breast Cancer.
作者: R W Carlson.;B O Anderson.;W Bensinger.;C E Cox.;N E Davidson.;S B Edge.;W B Farrar.;L J Goldstein.;W J Gradishar.;A S Lichter.;B McCormick.;L M Nabell.;E C Reed.;S M Silver.;M L Smith.;G Somlo.;R Theriault.;J H Ward.;E P Winer.;A Wolff.; .
来源: Oncology (Williston Park). 2000年14卷11A期33-49页
The therapeutic options for patients with noninvasive or invasive breast cancer are complex and varied. In many situations, the patient and physician have the responsibility to jointly explore and ultimately select the most appropriate option from among the available alternatives. With rare exception, the evaluation, treatment, and follow-up recommendations contained within these guidelines were based largely on the results of past and present clinical trials. However, there is not a single clinical situation in which the treatment of breast cancer has been optimized with respect to either maximizing cure or minimizing toxicity and disfigurement. Therefore, patient and physician participation in prospective clinical trials allows patients not only to receive state-of-the-art cancer treatment but also to contribute to the improvement of treatment of future patients.
1888. The NCCN guidelines development process and infrastructure.
A major task of the National Comprehensive Cancer Network (NCCN) is to develop pathways reflecting the major step-by-step management decisions required to provide care for patients with cancer. The determination of what is appropriate care involves assessing the balance between the sum of the benefits compared to the sum of the risks. The guidelines are composed of recommendations based on the best evidence available at the time they are derived. Each guideline is reviewed annually and once revisions have been uniformly accepted, the new version becomes the official NCCN guideline for that year.
1889. NCCN Practice Guidelines for Chronic Myelogenous Leukemia.
作者: E Berman.;R A Clift.;E A Copelan.;P D Emanuel.;H P Erba.;M J Glenn.;P L Greenberg.;R J Jones.;S O'Brien.;H I Saba.;R Schilder.;D S Snyder.;R J Soiffer.;M S Tallman.;M Wetzler.;F Ravandi-Kashani.;H Kantarjian.;M Talpaz.; .
来源: Oncology (Williston Park). 2000年14卷11A期229-40页 1890. General guidelines for the management of older patients with cancer.
Because aging is highly individualized, the best guide to treatment of the older patient with cancer may be provided by a comprehensive assessment that evaluates such diverse areas as functional status, comorbidity, socioeconomic conditions, nutrition, polypharmacy, and the presence or absence of geriatric syndromes. Aging is further associated with important pharmacologic changes that involve pharmacokinetics, pharmacodynamics, and the toxicity profile of the drugs. These changes increase the risk of therapeutic complications partly because of the different behavior of the disease in an older patient population and partly because of a decreased tolerance to treatment in some older patients.
1891. NCCN Practice Guidelines for Head and Neck Cancers.
作者: D G Pfister.;K Ang.;B Brockstein.;A D Colevas.;J Ellenhorn.;H Goepfert.;W L Hicks.;W K Hong.;M S Kies.;W Lydiatt.;T McCaffrey.;B B Mittal.;J A Ridge.;D E Schuller.;J P Shah.;S Spencer.;A Trotti.;S Urba.;E A Weymuller.;R H Wheeler.;G T Wolf.; .
来源: Oncology (Williston Park). 2000年14卷11A期163-94页 1892. Comprehensive Cancer Centre Amsterdam Barrett Advisory Committee: first results.
作者: J B Hulscher.;J Haringsma.;J Benraadt.;G J Offerhaus.; ten Kate FJ.;J P Baak.;G N Tytgat.; van Lanschot JJ.; .
来源: Neth J Med. 2001年58卷1期3-8页
Treatment and follow-up policy for Barrett's oesophagus are dependent on the grade of dysplasia. However, sampling error of random biopsy protocols and subjectivity of pathological grading may hamper endoscopic surveillance.
1893. Recommendations for handling radioactive specimens obtained by sentinel lymphadenectomy. Surgical Pathology Committee of the College of American Pathologists, and the Association of Directors of Anatomic and Surgical Pathology.
Sentinel lymph node biopsy has been shown to be an accurate predictor of axillary nodal status in invasive breast cancer and is a useful alternative to axillary dissection for some patients. Because radioactive materials are often used to identify the sentinel lymph node, concerns have been raised regarding the safe handling of tissue specimens obtained by this technique. The Surgical Pathology Committee of the College of American Pathologists and the Association of Directors of Anatomic and Surgical Pathology have developed recommendations for the safe handling of radioactive specimens obtained by sentinel lymphadenectomy.
1894. [Recommendations for the use of colposcopy].
作者: J J Baldauf.;R Barrasso.;D Benmoura.;B Huynh.;J L Mergui.;T Beuret.;B Blanc.;J Blondon.; .; .; .; .
来源: Gynecol Obstet Fertil. 2000年28卷9期667-71页 1896. Breast cancer diagnosis. Screening and evaluation. Institute for Clinical Systems Improvement.
来源: Postgrad Med. 2000年108卷5期191-2, 195-8, 201-4页
1897. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology.
作者: J L Benedet.;H Bender.;H Jones.;H Y Ngan.;S Pecorelli.
来源: Int J Gynaecol Obstet. 2000年70卷2期209-62页 1898. Stage III and IV Hodgkin's disease treatment guidelines. American College of Radiology. ACR Appropriateness Criteria.
作者: L R Prosnitz.;J M Connors.;R L Deming.;J Yahalom.;P M Mauch.;L S Constine.;D E Dosoretz.;A J Elman.;R T Hoppe.;D A Pistenmaa.;H B Wolkov.;A Chauvenet.;J H Glick.;S Leibel.
来源: Radiology. 2000年215 Suppl卷1257-68页 |